Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage. 2013 Feb; 45(2):159-69.
View in:
PubMed
subject areas
Adult
Benzhydryl Compounds
Central Nervous System Stimulants
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Fatigue
Female
Humans
Male
Middle Aged
Placebo Effect
Sarcoidosis
Sleep Apnea Syndromes
Treatment Outcome